During the past decade, Osaka Medical Center for Cancer and Cardiovascular Diseases conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Osaka Medical Center for Cancer and Cardiovascular Diseases" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 10 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Osaka Medical Center for Cancer and Cardiovascular Diseases" are "Gastric Neoplasm" (2 trials), "Carcinoma, Squamous Cell" (1 trials), "Colorectal Neoplasms" (1 trials), "Esophageal Neoplasms" (1 trials) and "Malignant Pericardial Effusion" (1 trials). Many other conditions were trialed in "Osaka Medical Center for Cancer and Cardiovascular Diseases" in a lesser frequency.

Most popular intervention types in "Osaka Medical Center for Cancer and Cardiovascular Diseases" are "Drug" (8 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "(Cisplatin 80 mg/㎡+5FU 800mg/㎡×5days)×2＋Surgery" (1 trials), "5FU+l-leucovorin" (1 trials), "Etoposide and cisplatin after chemoradiotherapy" (1 trials), "Gastrectomy with more than D2 dissection" (1 trials) and "Irinotecan and cisplatin after chemoradiotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Osaka Medical Center for Cancer and Cardiovascular Diseases" are 8 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Osaka Medical Center for Cancer and Cardiovascular Diseases". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Osaka Medical Center for Cancer and Cardiovascular Diseases, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Osaka Medical Center for Cancer and Cardiovascular Diseases, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".